South Korean specialists have created a drug for Parkinson's treatment
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Scientists from South Korea managed to create a new substance that effectively fights against Parkinson's disease. They published their work in one of the scientific publications.
Parkinson's disease affects mainly the elderly, which eventually destroys the cells of the brain. The action of the new drug in the human body is aimed at the production of special proteins that prevent the destruction of brain neurons.
In the course of animal studies, it was found that the new substance is more effective than existing drugs for the treatment of Parkinson's disease. In addition, the new drug has fewer side effects.
Prior to the discovery of a new drug, selective inhibitors, dopamine receptor agonists, were used in the world to treat medical conditions. But a research team headed by Dr. Pak Ki Dok (an employee of the Korea Institute of Science and Technology) and Professor Hwae He-Gyu (an employee of the University of Ulsan) created a completely new drug that scientists believe is more effective than the widely used treatment for Parkinson's Seligin , in addition, the new drug has an order of magnitude less side effects.
A new drug when ingested leads to an increase in some proteins that block the impairment of brain functions. As experts note, the drug acts directly on the brain and increases the level of proteins. The effectiveness of the new drug is 1.5 times greater than that of other modern drugs. Now scientists have only animal studies, but in the near future they plan to test the new drug on patients in clinics. Additional studies of the drug will help to establish whether it is possible to defeat the disease completely or not.
April 11, every year is marked with a day of struggle against Pakinson. The name of the disease is given in honor of a doctor from Britain who described the symptoms of the disease in the "Essay on the trembling paralysis". One of the main symptoms of the disease is trembling of the limbs, speech and motor function disorders. Over time, when the disease is progressing more and more, there are problems with the coordination of movement, sometimes because of illness a person may find himself in a wheelchair.
Dysfunction in the motor function in the disease, scientists attribute a lack in certain areas of the brain of dopamine, which leads to the death of cells that produce this neurotransmitter.
Recently, a group of scientists from Krasnoyarsk suggested a new technique in the treatment of Parkinson's and Alzheimer's. For ten years, specialists have studied these diseases and have recently been able to identify certain molecules that correspond to the development of pathological processes in the brain. This discovery will enable researchers to develop a new drug that could prevent the destruction of brain cells. In addition, the discovery of such molecules will help the pharmaceutical industry to create new more effective drugs.
[